See more : Regnum Corp. (RGMP) Income Statement Analysis – Financial Results
Complete financial analysis of Lumos Diagnostics Holdings Limited (LDX.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lumos Diagnostics Holdings Limited, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Mitre Realty Empreendimentos e Participações S.A. (MTRE3.SA) Income Statement Analysis – Financial Results
- Sanchuan Wisdom Technology Co., Ltd. (300066.SZ) Income Statement Analysis – Financial Results
- Goodman Group (GMGSF) Income Statement Analysis – Financial Results
- Silver Fields Resources Inc. (SFRFF) Income Statement Analysis – Financial Results
- Vanquis Banking Group plc (FPLPF) Income Statement Analysis – Financial Results
Lumos Diagnostics Holdings Limited (LDX.AX)
About Lumos Diagnostics Holdings Limited
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 11.13M | 10.54M | 11.63M | 18.85M | 5.79M | 4.48M | 1.92M |
| Cost of Revenue | 4.03M | 4.56M | 7.17M | 10.25M | 3.28M | 2.44M | 1.08M |
| Gross Profit | 7.10M | 5.97M | 4.46M | 8.60M | 2.51M | 2.04M | 839.22K |
| Gross Profit Ratio | 63.77% | 56.69% | 38.31% | 45.62% | 43.35% | 45.45% | 43.72% |
| Research & Development | 69.00K | 421.00K | 1.33M | 1.24M | 2.07M | 2.70M | 276.51K |
| General & Administrative | 10.45M | 10.09M | 16.86M | 9.77M | 9.50M | 2.45M | 1.40M |
| Selling & Marketing | 289.00K | 135.00K | 2.27M | 1.03M | 1.82M | 1.96M | 600.16K |
| SG&A | 10.74M | 10.22M | 19.13M | 18.36M | 11.32M | 4.41M | 2.00M |
| Other Expenses | -3.71M | 2.00M | 17.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.10M | 15.50M | 25.53M | 19.41M | 11.34M | 7.14M | 2.11M |
| Cost & Expenses | 16.14M | 17.14M | 32.70M | 29.67M | 14.63M | 9.58M | 3.19M |
| Interest Income | -96.00K | 21.00K | 572.00K | 4.22M | 507.94K | 104.29K | 0.00 |
| Interest Expense | 975.00K | 371.00K | 172.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.65M | 3.67M | 2.82M | 311.00K | 305.73K | 128.87K | 58.12K |
| EBITDA | -5.44M | -4.93M | -18.67M | -10.69M | -10.41M | -2.76M | -1.23M |
| EBITDA Ratio | -48.84% | -40.64% | -160.54% | -56.70% | -179.73% | -61.57% | -64.01% |
| Operating Income | -5.01M | -10.24M | -21.49M | -11.00M | -10.72M | -2.89M | -1.29M |
| Operating Income Ratio | -44.99% | -97.16% | -184.82% | -58.35% | -185.00% | -64.45% | -67.04% |
| Total Other Income/Expenses | -3.58M | -2.41M | -21.84M | -4.03M | 1.53M | -2.32M | 20.37K |
| Income Before Tax | -8.59M | -8.97M | -45.72M | -15.03M | -9.34M | -5.21M | -1.27M |
| Income Before Tax Ratio | -77.19% | -85.15% | -393.16% | -79.72% | -161.18% | -116.21% | -65.98% |
| Income Tax Expense | 0.00 | 2.37M | 189.00K | 0.00 | 59.35K | 611.23K | 0.00 |
| Net Income | -8.59M | -8.97M | -45.72M | -15.03M | -9.28M | -4.60M | -1.27M |
| Net Income Ratio | -77.19% | -85.15% | -393.16% | -79.72% | -160.16% | -102.57% | -65.98% |
| EPS | -0.02 | -0.04 | -0.30 | 0.00 | -0.42 | -0.27 | 0.00 |
| EPS Diluted | -0.02 | -0.04 | -0.30 | 0.00 | -0.42 | -0.27 | 0.00 |
| Weighted Avg Shares Out | 463.21M | 234.85M | 152.31M | 0.00 | 22.20M | 16.88M | 0.00 |
| Weighted Avg Shares Out (Dil) | 463.19M | 234.84M | 152.32M | 0.00 | 22.21M | 16.88M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports